Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial oxidative phosphorylation (OXPHOS) system, integrated with its essential phospholipid environment (notably cardiolipin), is the primary site of cellular energy production via ATP synthesis (Paradies et al., 2019, PMID: 31100344). This system consists of five multi-subunit protein complexes (I-V) embedded in the inner mitochondrial membrane, where phospholipids provide the structural scaffold and functional support necessary for electron transfer and proton gradient maintenance (Mejia and Hatch, 2016, PMID: 26703187). Cardiolipin, a unique dimeric phospholipid, is particularly critical as it anchors the respiratory complexes into "supercomplexes" to enhance efficiency and minimize reactive oxygen species (ROS) leakage (Szeto, 2014, PMID: 24102316). Dysregulation of this system, often involving cardiolipin peroxidation or complex mutations, is a hallmark of mitochondrial myopathies, heart failure, and neurodegenerative disorders (Chinnery, 2015, PMID: 25582790). Therapeutic strategies targeting this system include small molecules like elamipretide, which binds to cardiolipin to stabilize the membrane-protein interface and restore bioenergetics (Szeto, 2014, PMID: 24102316). However, because OXPHOS is fundamental to almost all cell types, pharmacological intervention carries risks of systemic toxicity and metabolic disruption such as lactic acidosis (Owen et al., 2000, PMID: 10839993).
Stabilization of the inner mitochondrial membrane and respiratory supercomplexes through lipid-protein interactions, or direct modulation of electron transport chain complex activity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial oxidative phosphorylation system and associated phospholipids (OXPHOS).